Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2024 16:05 ET | Source: Cytek Biosciences, Inc.

Cytek Biosciences to Participate in Upcoming Investor Conferences

FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
October 29, 2024 16:05 ET | Source: Cytek Biosciences, Inc.

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

FREMONT, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third...
September 18, 2024 17:00 ET | Source: Cytek Biosciences, Inc.

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
September 12, 2024 15:20 ET | Source: Cytek Biosciences, Inc.

Cytek Announces Resignation of Chief Operating Officer Chris Williams

FREMONT, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris...
August 21, 2024 17:00 ET | Source: Cytek Biosciences, Inc.

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Cytek announced that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification.
August 08, 2024 16:05 ET | Source: Cytek Biosciences, Inc.

Cytek Biosciences to Participate in Upcoming Investor Conferences

FREMONT, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
August 06, 2024 16:05 ET | Source: Cytek Biosciences, Inc.

Cytek Biosciences Reports Second Quarter 2024 Financial Results

FREMONT, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
July 30, 2024 17:00 ET | Source: Cytek Biosciences, Inc.

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Cytek has developed a revolutionary tool to automate panel design. SpectroPanel is an intelligent algorithm that suggests optimized panels in minutes.
July 30, 2024 16:05 ET | Source: Cytek Biosciences, Inc.

Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024

FREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the second...
June 06, 2024 08:00 ET | Source: Cytek Biosciences, Inc.

Cytek Biosciences Announces $50 Million Stock Repurchase Program

FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the...